Beeovita
Freka-Clyss Enema Liquid - Empty the Intestines Safely
Freka-Clyss Enema Liquid - Empty the Intestines Safely

Freka-Clyss Enema Liquid - Empty the Intestines Safely

Freka Clyss Klistier 20 Fl 133 ml

Freka-Clyss is an enema liquid designed to empty the intestines safely and efficiently. It is particularly suitable for cases where oral laxatives can cause irritation or when preparing for intestinal examinations. Shop now!
  • 64.65 USD

In stock
Cat. Y
Available 29 pieces
Safe payments
Amount in a pack. 20
Storage temp. min 15 / max 25 ℃
Enema Freka-clyss Enemas

Description

Freka-Clyss is an enema liquid for emptying the intestines.

Freka-Clyss does not affect the upper parts of the intestine, so it is particularly suitable in cases where oral laxatives are not appropriate or can lead to irritation, e.g. in preparation for intestinal examinations.

Freka-Clyss can also be used in patients who should avoid straining to defecate.

Swissmedic-approved patient information

Freka-Clyss®

Fresenius Kabi (Schweiz) AG

What is Freka-Clyss and when is it used?

Freka-Clyss is an enema liquid for emptying the intestines.

Freka-Clyss does not affect the upper parts of the intestine, so it is particularly suitable in cases where oral laxatives are not appropriate or can lead to irritation, e.g. in preparation for intestinal examinations.

Freka-Clyss can also be used in patients who should avoid straining to defecate.

What should be considered?

As with all laxatives, abuse of Freka-Clyss can lead to addiction.

When should Freka-Clyss not be used?

Freka-Clyss should only be used if necessary. Freka-Clyss should not be administered in the case of nausea, vomiting, stomach ulcers, colon abnormalities and acute renal failure.

If there is a tear in the lining of the rectum (fissure in the rectum or anal canal), Freka-Clyss must not be administered because of the risk of perforation.

Freka-Clyss must not be administered to infants, toddlers and children under the age of 12 because of the risk of serious adverse effects that may be fatal (see also the note under “When should caution be exercised when using Freka-Clyss?, Children” ).

When is caution required when using Freka-Clyss?

If Freka-Clyss is used repeatedly, the intestinal mucosa absorbs part of the sodium contained in the solution . This must be taken into account in patients with heart disease, kidney disease and hypertension.

Incorrect use can damage the intestinal mucosa. The phosphate solution can then cause inflammation and tissue destruction. Intestinal perforation can also occur. A doctor should be contacted immediately if there is a change in general well-being, pain or bleeding from the anus after administration of Freka-Clyss.

Children

Freka-Clyss must not be used in infants, small children and children under 12 years of age. Use in children can lead to serious complications, including fatal outcomes, in particular electrolyte disorders, especially increased serum phosphate (hyperphosphatemia) and reduced serum calcium (hypocalcaemia) and their clinical consequences such as tetany and cardiac arrhythmia.

The treatment of older children and adolescents with Freka-Clyss should therefore be carried out with the necessary caution.

Inform your doctor, pharmacist or druggist if you suffer from other illnesses, have allergies or use other medicines (including those you have bought yourself!)!

Freka-Clyss contains methyl parahydroxybenzoate (E 218), which can cause allergic reactions, including delayed reactions. Freka-Clyss should not be used in patients with a methylparaben allergy.

Freka-Clyss contains 133 mg sodium benzoate (E 211) per bottle.

Can Freka-Clyss be used during pregnancy or while breastfeeding?

Freka-Clyss should not be used at the beginning of pregnancy, or if there is a risk of miscarriage or premature birth . Systemic scientific investigations were not carried out. To be on the safe side, you should avoid taking medicines during pregnancy and breastfeeding or ask your doctor, pharmacist or druggist for advice. During breast-feeding, Freka-Clyss should only be used in urgent cases.

How do you use Freka-Clyss?

Adults and adolescents aged 12 and over need 1 bottle. In stubborn cases and for special clinical use: 2-3 bottles in succession. In general, applying Freka-Clyss half an hour beforehand is sufficient to prepare for examinations.

Freka-Clyss should be used at room temperature (15-25°C)!

Stick to the dosage given in the package insert or prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist. Freka-Clyss should be used as follows: see instructions for use.

What side effects can Freka-Clyss have?

The following side effects can occur:

No side effects have been observed for Freka-Clyss when used correctly. It can still cause discomfort (irritation, cramps). Freka-Clyss can lead to increased phosphate levels (hyperphosphataemia) or reduced calcium levels in the blood (hypocalcaemia), especially in the case of incorrect use and non-observance of the contraindications. If you notice any side effects that are not described here, you should inform your doctor, pharmacist or druggist.

What else needs to be considered?

Freka-Clyss may only be used up to the point marked «Exp.» on the container. designated date are used. Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

Store at room temperature (15-25°C).

Keep out of the reach of children.

What is included in Freka-Clyss?

Freka-Clyss includes:

Active ingredients

Sodium dihydrogen phosphate anhydrous 139.1 mg/ml, sodium monohydrogen phosphate 31.8 mg/ml

Excipients

Sodium benzoate (E211), methyl parahydroxybenzoate (E218), sodium hydroxide (for pH adjustment), purified water

Approval number

36308 (Swissmedic).

Where can you get Freka-Clyss? What packs are available?

Freka-Clyss is available in pharmacies and drugstores without a doctor's prescription.

Packs of 1 x 133 ml and multipacks of 20 x 133 ml are available.

Authorization holder

Fresenius Kabi (Switzerland) AG, 6010 Kriens.

This leaflet was last checked by the Medicines Agency (Swissmedic) in June 2021.

Reviews (0)

Beeovita
Huebacher 36
8153 Rümlang
Switzerland
Free
expert advice